mAbs

mAbs is a multi-disciplinary journal dedicated to the art and science of antibody research and development. The journal has a strong scientific and medical focus, but also strives to serve a broader readership. The articles are thus of interest to scientists, clinical researchers, and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics.

mAbs 是一本多学科、开放获取的期刊，致力于抗体研究和开发的艺术和科学。 该杂志以科学和医学为重点，但服务于广泛的读者，包括技术转让、法律问题、投资、规划和治疗监管方面的专家。 mAb 涵盖一系列主题，包括： 抗体疗法的工程和选择，包括抗体-药物偶联物、多特异性抗体和单域抗体； 机器学习和人工智能应用； 抗体的非临床研究，例如作用机制研究、动物安全性和有效性研究； 制造和配方； 抗体疗法的监管审查。